Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17480197 | 0.83 | ALDH1A1 (0.32) | — | |
| SCHEMBL1832184 | 0.79 | LMNA (0.38) | BLMLMNASLC6A6CYP2C19APP | |
| SCHEMBL34463483 | 0.78 | CA12 (0.45) | LMNACYP2C19PMP22 | |
| SCHEMBL1070050 | 0.78 | — | — | |
| SCHEMBL932090 | 0.77 | LMNA (0.36) | BLMLMNASLC6A6CYP2C19APP | |
| Ethylenediamine SCHEMBL29866013 | 0.77 | SMPD1 (0.44) | FDPS | |
| SCHEMBL6018675 | 0.76 | FDPS (0.33) | LMNAFDPS | |
| Ammonia Solution, Strong SCHEMBL21625541 | 0.76 | CYP2D6 (0.33) | BLMLMNASLC6A6CYP2C19APP | |
| SCHEMBL28815551 | 0.76 | CYP2D6 (0.33) | BLMLMNASLC6A6CYP2C19APP | |
| SCHEMBL28613244 | 0.76 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3999833-A1 | METHOD FOR DETERMINING AT LEAST ONE PARAMETER OF A SAMPLE COMPOSITION COMPRISING NUCLEIC ACID, SUCH AS RNA, AND OPTIONALLY PARTICLES | BioNTech SE (DE) | 2022-05-25 | — | — | EP | claimed |
| EP-3881050-A1 | METHOD, SOLUTION AND KIT FOR PREPARING A TISSUE SAMPLE FOR 3D IMAGING | The Francis Crick Institute Limited (GB) | 2021-09-22 | — | — | EP | claimed |
| WO-2021009368-A1 | METHOD FOR DETERMINING AT LEAST ONE PARAMETER OF A SAMPLE COMPOSITION COMPRISING NUCLEIC ACID, SUCH AS RNA, AND OPTIONALLY PARTICLES | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2021-01-21 | — | — | WO | claimed |
| WO-2020099870-A1 | METHOD, SOLUTION AND KIT FOR PREPARING A TISSUE SAMPLE FOR 3D IMAGING | THE FRANCIS CRICK INSTITUTE LIMITED (GB) | 2020-05-22 | — | — | WO | claimed |
| CN-103620409-B | Immunoassay method and reagent for reducing non-specific binding | 阿波特日本有限公司 | 2017-04-12 | — | — | CN | claimed |
| EP-2973408-A2 | A SYSTEM AND METHODS FOR THE IN VITRO DETECTION OF PARTICLES AND SOLUBLE CHEMICAL ENTITIES IN BODY FLUIDS | Turner, Richard Harry (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014141034-A2 | A SYSTEM AND METHODS FOR THE IN VITRO DETECTION OF PARTICLES AND SOLUBLE CHEMICAL ENTITIES IN BODY FLUIDS | TURNER RICHARD HARRY (US) | 2014-09-18 | — | — | WO | claimed |
| WO-2013009927-A2 | DROPLET ACTUATORS AND TECHNIQUES FOR DROPLET-BASED ASSAYS | ADVANCED LIQUID LOGIC, INC. (US) | 2013-01-17 | — | — | WO | claimed |
| CN-102753476-A | Carbon nanotube sheet and process for production thereof | UNIV HOKKAIDO NAT UNIV CORP | 2012-10-24 | — | — | CN | claimed |
| EP-1601966-A4 | METHODS AND COMPOSITIONS FOR PURIFICATION OF NUCLEIC ACID FROM A HOST CELL | EPPENDORF 5 PRIME INC (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2005111608-A2 | TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY TEST REAGENTS AND METHODS USING THEM | IDEXX LABORATORIES, INC. (US) | 2005-11-24 | — | — | WO | claimed |
| WO-2005039381-A2 | COMPOSITIONS AND PROCESSES FOR ANALYSIS OF PHARMACOLOGIC AGENTS IN BIOLOGICAL SAMPLES | DRUG RISK SOLUTIONS, L.L.C. (US) | 2005-05-06 | — | — | WO | claimed |
| WO-2005007895-A1 | METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES | APPLERA CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| WO-2004081175-A2 | METHODS AND COMPOSITIONS FOR PURIFICATION OF NUCLEIC ACID FROM A HOST CELL | EPPENDORF AG (DE) | 2004-09-23 | — | — | WO | claimed |
| EP-1021463-A1 | FACTOR G REDUCED AMEBOCYTE LYSATES FOR DETECTION OF BACTERIAL ENDOTOXINS | Charles River Laboratories (US) | 2000-07-26 | — | — | EP | claimed |
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| WO-1999019355-A1 | FACTOR G REDUCED AMEBOCYTE LYSATES FOR DETECTION OF BACTERIAL ENDOTOXINS | CHARLES RIVER LABORATORIES (US) | 1999-04-22 | — | — | WO | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| EP-0864091-A1 | REAGENT SYSTEM AND METHOD FOR THE DIFFERENTIATION AND IDENTIFICATION OF RETICULOCYTES | Abbott Laboratories (US) | 1998-09-16 | — | — | EP | claimed |
| WO-1997019356-A1 | REAGENT SYSTEM AND METHOD FOR THE DIFFERENTIATION AND IDENTIFICATION OF RETICULOCYTES | ABBOTT LABORATORIES (US) | 1997-05-29 | — | — | WO | claimed |